Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

KKR & Co LP To Buy Clinical Trials Company-Reuters


Wednesday, 31 Jul 2013 05:38pm EDT 

Reuters reported that KKR & Co LP said on July 31, 2013 it had agreed to acquire ReSearch Pharmaceutical Services Inc (RPS) from private-equity peer Warburg Pincus LLC. Terms of the deal were not disclosed. 

Company Quote

23.99
-0.4 -1.64%
11:05am EST